Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactived Split Influenza Vaccine in Healthy Infants
Clinical trial NCT04381689 · COMPLETED
Trial details
- NCT number
- NCT04381689
- Sponsor
- Il-Yang Pharm. Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-23
- Primary completion
- 2025-05-20
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.